Purchase Order 75N91023P00187
Award Date 1/9/23
Potential Completion Date 2/4/23
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,616 purchase order to Emulate Inc., doing business as Emulate, located in Rockville, Maryland. The contract is for a one-year period starting December 20, 2023 through December 19, 2024 to provide a complete human emulation system as a service. No subcontractors or set aside designations were identified. The National Cancer Institute supports research to advance cancer prevention,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) on June 1, 2020. The $130,163.45 contract, titled "EMULATE: ESTABLISHING ORGAN-CHIP MODELS FOR STUDYING RADIATION-INDUCED NORMAL TISSUE INJURY AND IDENTIFYING RNA BIOMARKERS FOR RADIATION BIODOSIMETRY," is for the development of an automated microfluidic cell culture system of human...
- This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
- This is a federal contract award from the U.S. Army Research, Development and Engineering Command (RDECOM) to Emulate Inc., a biotechnology company specializing in organ-on-chip technology. The $82,750.02 firm fixed-price purchase order is for the delivery of "LIVER HEALTHY QUAD #CULTURE KITS." Emulate, a for-profit organization based in Boston, Massachusetts, has a history of supplying advanced microphysiological systems and associated services to various federal agencies, primarily...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) for a "Service Agreement for Zoe". The contract has a ceiling value of $19,096.00 and a period of performance through May 30, 2026. It was awarded on May 31, 2024 and was not set aside for any specific business category. Emulate is a biotechnology...
- The U.S. Food and Drug Administration awarded a $200.3K purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems, for the procurement of a Human Emulation System. The contract, awarded on March 29, 2023, with an ultimate completion date of October 1, 2023, carries a Total Small Business set-aside designation and employs firm fixed-price pricing. The award supports FDA's regulatory science initiatives and efforts to advance...